Logo Light ModeLogo Dark Mode
Why Subscribe?About UsAccreditationLearning Hub CentralLive EventsBlog

Learning Hub Central

Loading…

Contact Us

info@meccinc.com
(305) 663-1628
MEC LogoMEC MedPro LogoMEC Series LogoGlobal Meetings Logo

© 2026 MyMedFlix, All Rights Reserved.

Powered By CMEGenius™
Privacy PolicyTerms and ConditionsCancellation and Refund PolicyAI Disclosure

Learning Hub Central

Filter by title, faculty, or specialty to find the course you're looking for.

SpecialtyHematology(23 courses)
All specialties

Hematology

23 courses

2026 Updates in Cancer Therapies | Updates on B-Cell NHL

2026 Updates in Cancer Therapies | Updates on B-Cell NHL

0.00 Credits
1 Chapter
Hematology
Free
2026 Updates in Cancer Therapies | State-of-the-Art Treating De Novo Multiple Myeloma in 2026

2026 Updates in Cancer Therapies | State-of-the-Art Treating De Novo Multiple Myeloma in 2026

0.00 Credits
1 Chapter
Hematology
Free
2026 Updates in Cancer Therapies | Updates in CML and CLL

2026 Updates in Cancer Therapies | Updates in CML and CLL

0.00 Credits
1 Chapter
Hematology
Free
2025 Advances in Oncology | Update on Hemophilia Management

2025 Advances in Oncology | Update on Hemophilia Management

0.00 Credits
1 Chapter
Hematology
Free
2025 CCC | Lymphoma: State of the Art and Future Directions

2025 CCC | Lymphoma: State of the Art and Future Directions

0.00 Credits
1 Chapter
Hematology
Free
2025 CCC | Advances in the Treatment of Acute Leukemias and MDS

2025 CCC | Advances in the Treatment of Acute Leukemias and MDS

0.00 Credits
1 Chapter
Hematology
Free
2025 CCC | New Frontiers in Cellular Therapies for Cancer

2025 CCC | New Frontiers in Cellular Therapies for Cancer

0.00 Credits
1 Chapter
Hematology
Free
2025 CCC | Bispecifics in Hematologic Malignancies

2025 CCC | Bispecifics in Hematologic Malignancies

0.00 Credits
1 Chapter
Hematology
Free
2025 CCC | How to Get a CTEP LOI Approved

2025 CCC | How to Get a CTEP LOI Approved

0.00 Credits
1 Chapter
Hematology
Free
2025 NOSCM | Waldenstrom’s Macroglobulinemia

2025 NOSCM | Waldenstrom’s Macroglobulinemia

0.00 Credits
1 Chapter
Hematology
Free
2025 NOSCM | Clinical Challenges in the Management of Thrombosis and Acquired Inhibitors in Cancer Patients

2025 NOSCM | Clinical Challenges in the Management of Thrombosis and Acquired Inhibitors in Cancer Patients

0.00 Credits
1 Chapter
Hematology
Free
2025 NOSCM | Chimeric Antigen Receptor T-cell Therapy in B-cell lymphomas: Is Cure A Reality or Is It Still Just A Promise?

2025 NOSCM | Chimeric Antigen Receptor T-cell Therapy in B-cell lymphomas: Is Cure A Reality or Is It Still Just A Promise?

0.00 Credits
1 Chapter
Hematology
Free
2025 MLS Nashville | IV Iron Deficiency Anemia | IV Clinical and Practice Considerations

2025 MLS Nashville | IV Iron Deficiency Anemia | IV Clinical and Practice Considerations

0.00 Credits
1 Chapter
Hematology
Free
What New in Hematopoietic Stem Cell Transplantation

What New in Hematopoietic Stem Cell Transplantation

0.00 Credits
1 Chapter
Hematology
Free
Plasma Cell Disorder

Plasma Cell Disorder

0.00 Credits
1 Chapter
Hematology
Free
Hematology Session I

Hematology Session I

0.00 Credits
1 Chapter
Hematology
Free
Hematology Session II

Hematology Session II

0.00 Credits
1 Chapter
Hematology
Free
Hematology Session III

Hematology Session III

0.00 Credits
1 Chapter
Hematology
Free
2021 MCM | Hematology Malignancies Session

2021 MCM | Hematology Malignancies Session

0.00 Credits
1 Chapter
Hematology
Free
Panel Discussion: Practice Changing Developments in Benign and Malignant Hematology

Panel Discussion: Practice Changing Developments in Benign and Malignant Hematology

0.00 Credits
1 Chapter
Hematology
Free
2021 AIO | State of the Art Management of Sickle Cell Anemia

2021 AIO | State of the Art Management of Sickle Cell Anemia

0.00 Credits
1 Chapter
Hematology
Free
2024 SPS Seattle | Clinical Update: Malignant Hematology

2024 SPS Seattle | Clinical Update: Malignant Hematology

0.00 Credits
1 Chapter
Hematology
Free
2021 NOSCM | New Agents and New Toxicities in Malignant Hematology: BCL2 Inhibitors, Anti-BCMA, and FLT3 Inhibitors

2021 NOSCM | New Agents and New Toxicities in Malignant Hematology: BCL2 Inhibitors, Anti-BCMA, and FLT3 Inhibitors

0.00 Credits
1 Chapter
Hematology
Free

Contact Us

info@meccinc.com
(305) 663-1628
MEC LogoMEC MedPro LogoMEC Series LogoGlobal Meetings Logo

© 2026 MyMedFlix, All Rights Reserved.

Powered By CMEGenius™
Privacy PolicyTerms and ConditionsCancellation and Refund PolicyAI Disclosure